Gonadotropin-Releasing Hormone Antagonists Revolutionizing Gynecology

In: Obstetrics & Gynecology · 2022 · vol. 140(6) , pp. 917–919 · doi:10.1097/aog.0000000000005012 · PMID:36357969 · W4308769674
letter OA: closed CC0
View on OpenAlex View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-06

This review discusses the advancements and clinical applications of gonadotropin-releasing hormone antagonists in gynecological treatment and management.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Ecem Esencan and Hugh S. Taylor are from Department of Obstetrics, Gynecology, and Reproductive Sciences at Yale University School of Medicine, New Haven, Connecticut; email: [email protected]. Financial Disclosure Hugh S. Taylor received grant support from AbbVie to Yale University to support Dr. Taylor's research. Ecem Esencan did not report any potential conflicts of interest.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

References (17)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK